大疱性类天疱疮合并神经精神共病与抗BP230抗体血清阳性相关
该回顾性研究纳入2009–2020年一家三级转诊中心的273例大疱性类天疱疮(BP)患者,其中123例(45.1%)存在神经精神共病。多因素分析显示,抗BP230抗体血清阳性与BP合并神经精神疾病独立相关(校正OR 3.43,95%CI 1.24–9.52,P=0.018)。
要点
- BP患者中神经精神共病常见,约占45.1%。
- 合并神经精神疾病者抗BP230血清阳性率更高(67.7% vs 36.5%)。
- 抗BP230血清阳性与神经精神共病独立相关(校正OR 3.43)。
核心结论
- BP与神经精神疾病共存独立关联于抗BP230抗体的产生。
研究设计与样本
- 回顾性研究,纳入2009–2020年一家三级转诊中心诊断的273例BP患者。
- 采用多因素logistic回归模型识别BP患者中神经精神疾病的预测因素。
主要发现
- 123例(45.1%)BP患者存在神经精神共病,其余150例无此共病。
- 合并神经精神疾病组平均年龄更高(81.7 vs 76.9岁,P<0.001),女性比例更高(65.0% vs 49.3%,P=0.009)。
- 合并神经精神疾病组抗BP230血清阳性率更高(67.7% vs 36.5%,P=0.006),抗BP180 NC16A IgG水平更高(651.3 vs 370.4 U/mL,P=0.039)。
- 多因素分析中抗BP230血清阳性与神经精神共病独立相关(校正OR 3.43,95%CI 1.24–9.52,P=0.018)。
- 限于神经系统疾病患者(n=103)的敏感性分析中,年龄更高(82.1 vs 77.2岁,P<0.001)和抗BP230血清阳性率更高(68.0% vs 39.7%,P=0.018)被识别。
临床怎么用
- 对BP患者应关注神经精神共病筛查,尤其抗BP230血清阳性者。
- 抗BP230血清阳性可能提示BP患者合并神经精神疾病的风险更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While clustering of bullous pemphigoid (BP) with neuropsychiatric diseases is well-established, the clinical and immunological profile of BP patients with this comorbidity remains to be decisively determined. OBJECTIVES: To evaluate the burden of neurological and psychiatric comorbidities among patients with BP and to elucidate the clinical, immunological and immunopathological features of patients with BP and comorbid neuropsychiatric conditions. METHODS: We performed a retrospective study encompassing patients diagnosed with BP throughout the years 2009-2020 in a specialized tertiary referral centre. Multivariate logistic regression model was used to identify predictors of neuropsychiatric conditions among patients with BP. RESULTS: The study included 273 patients with BP, of whom 123 (45.1%) presented with comorbid neuropsychiatric disease. Compared to the remaining patients with BP (n = 150), those with pre-existing neuropsychiatric diseases demonstrated older mean [standard deviation (SD)] age [81.7 (9.1) vs. 76.9 (10.1); P < 0.001], female preponderance (65.0% vs. 49.3%; P = 0.009), higher seropositivity rate of anti-BP230 (67.7% vs. 36.5%; P = 0.006) and higher levels of anti-BP180 NC16A IgG [651.3 (1279.6) vs. 370.4 (818.6) U/mL; P = 0.039]. In multivariate analysis, anti-BP230 seropositivity was independently associated with coexistence of BP with neuropsychiatric conditions [adjusted odds ratio (OR), 3.43; 95% CI, 1.24-9.52; P = 0.018]. In a sensitivity analysis confined to patients with neurological diseases (n = 103), older age [82.1 (8.4) vs. 77.2 (10.3); P < 0.001] and increased anti-BP230 seropositivity (68.0% vs. 39.7%; P = 0.018) were identified. CONCLUSIONS: The coexistence of BP with neuropsychiatric diseases is independently associated with the generation of anti-BP230 antibodies.
引用
- Ständer S, Hammers CM, Vorobyev A, et al. Coexistence of bullous pemphigoid with neuropsychiatric comorbidities is associated with anti-BP230 seropositivity. J Eur Acad Dermatol Venereol. 2021. PMID: 33896070. doi:10.1111/jdv.17304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。